NEW YORK CARDIOLOGICAL SOCIETY INC
Balance Sheet
Fiscal Year: 2024
Assets in 2024 (Year End)
$838,485
Other Assets
84%
Cash & Equivalents
16%
Prepaid Expenses
<1%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Liabilities in 2024 (Year End)
$4,375
Deferred Revenue
>99%
Payables & Accruals
0%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$131,973
$130,747
-1%
Receivables (Non-Related)
$0
$0
-
Related-Party Receivables
$0
$0
-
Inventories
$0
$0
-
Prepaid Expenses
$1,040
$1,071
+3%
Investments
$0
$0
-
Property, Plant, & Equipment (net)
$0
$0
-
Other Assets
$706,668
$706,667
0%
Total Assets
$839,681
$838,485
0%
Liabilities
2023
2024
Change
Payables & Accruals
$1,940
-
-
Grants Payable
-
-
-
Deferred Revenue
$4,630
$4,375
-6%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$6,570
$4,375
-33%
Net assets
2023
2024
Change
Restricted Net Assets
$75,000
$75,000
+0%
Unrestricted Net Assets
$758,111
$759,110
+0%
Net assets
2023
2024
Change
Net assets
+$833,111
+$834,110
+0%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)